"Transforming Clinical Research: Harnessing Emerging Technologies for Personalized Medicine and Evidence Generation"

Christopher Boone, PhD, Group Vice President of Research Services for Oracle Life Sciences will present "Transforming Clinical Research: Harnessing Emerging Technologies for Personalized Medicine and Evidence Generation" as part of the DCRI Research Forum series.

During his presentation Boone will take a deep dive into:
• The future of medicine - precision medicine enabling personalized treatments by integrating real-world data (RWD), genomics, and artificial intelligence (AI).
• The Convergence of RWD, Genomics, AI, and Digital Technologies Will Transform Evidence Generation: As biopharma companies adopt an integrated approach to evidence generation, emerging technologies like AI, digital twins, and advanced analytics will revolutionize trial design and execution. These innovations will make clinical research more adaptive, efficient, and patient-focused.
• Bridging the Hospital-Research Divide: Envisioning a more efficient, effective, person-centered, and inclusive clinical trials enterprise integrated with routine healthcare delivery. A unified data ecosystem catering to clinical care and research needs will help establish a true "learning health system."